Gingko bioworks stock.
Those are some eye-opening estimates, particularly since the leader in synthetic biomanufacturing, Ginkgo Bioworks (DNA 2.16%), currently has a market cap of $6 billion and trades for a little ...
1. Ginkgo Bioworks. Ginkgo Bioworks is a biotech company that went public through a special purpose acquisition company last year. The company has the backing of Bill Gates and can design and ...Ginkgo Bioworks ( NYSE: DNA) stock jumped 9% in early trading after it announced it was teaming up with Pfizer ( PFE) to develop RNA-based drug candidates. Under the deal, Ginkgo will receive an ...Ginkgo Bioworks Holdings Stock Forecast. All Analysts Top Analysts Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for DNA stock stock is $1.88, which predicts an increase of 45.74%. The lowest target is $1.25 and the highest is $2.50. On average, analysts rate DNA stock stock as a sell.29 de ago. de 2023 ... A key announcement is driving shares of DNA stock more than 20% higher today. Ginkgo Bioworks is making waves in the AI world.
Ginkgo Bioworks Holdings Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 29, 2023 7:59 p.m. EST Delayed quote $ 1.4200 0.03 2.16% After Hours Volume: 270.43K Advanced... Ginkgo Bioworks on going public in $15 billion SPAC deal. Boston-based biotech company Ginkgo Bioworks will make its market debut by merging with Soaring Eagle Acquisition Corp., the blank-check ...
Ginkgo Bioworks Holdings Inc. analyst ratings, historical stock prices, earnings estimates & actuals. DNA updated stock price target summary.
First quarter 2023 Total revenue of $81 million, down from $168 million in the comparable prior year period, a decrease of 52% driven by the expected ramp down of K-12 testing in Ginkgo's ...Barron's 400. Research & Ratings. U.S.: NYSE. About Ginkgo Bioworks Holdings Inc. Research & Ratings. Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes ...The Ginkgo Bioworks Holdings Inc (DNA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $3.8461, representing a +163.43% increase from the current price of $1.46.The highest analyst price target is …Ginkgo Bioworks (NYSE:DNA) Is among the more prominent stocks in the synthetic biology space. The company is located in Boston, Massachusetts, which is a …Find out the direct holders, institutional holders and mutual fund holders for Ginkgo Bioworks Holdings, Inc. (DNA).
Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $299,400, According to a Recent SEC Filing. MT. Nov. 17. Ginkgo Bioworks Holdings Insider Sold Shares Worth $112,837, According to a Recent SEC Filing. MT. Summary. Quotes. Charts.
Sep 17, 2021 · Boston-based Ginkgo Bioworks began trading on the New York Stock Exchange on Friday, becoming the latest company to close a SPAC merger and go public. Shares opened at $11.15 apiece under ticker ...
16 de nov. de 2022 ... Ginkgo has granted BTIG, the sole book-running manager for the offering, a 30-day option to purchase up to an additional $15 million shares ...11 de mai. de 2021 ... If Ginkgo Bioworks was priced at the same valuation as the basket average we mentioned earlier – a ratio of 27 – their market cap would fall to ...Is Ginkgo Bioworks a stock worth buying? When the stock began trading in September 2021, its valuation was around $15 billion. Today, it has a market capitalization of just $3.2 billion.17 de set. de 2021 ... The New York Stock Exchange welcomes Ginkgo Bioworks (NYSE: DNA) in celebration of its listing. To honor the occasion, Jason Kelly, CEO, ...See the company profile for Ginkgo Bioworks Holdings, Inc. (DNA) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...Oct 4, 2023 · Ginkgo Bioworks (DNA 8.53%) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood. Wood's confidence in ...
Ginkgo Bioworks' ( NYSE: DNA) first quarter results were something of a mixed bag, with continued progression on a number of metrics offset by rising costs and declining revenues. Ginkgo's success ...Oct 4, 2023 · Ginkgo Bioworks (DNA 8.53%) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood. Wood's confidence in ... With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.DNA - Ginkgo Bioworks Holdings Inc - Stock screener for investors and traders, financial visualizations.For those who are bullish on Ginkgo Bioworks, today's sell-off represents a good buying opportunity. The stock's drop doesn't reflect a fundamental concern that has emerged with the company.Ginkgo Bioworks (DNA): Insiders are selling Cathie Wood-backed stock. Ginkgo Bioworks (NYSE: DNA) stock price is nearing the lowest level on record as its …
11 de mai. de 2021 ... If Ginkgo Bioworks was priced at the same valuation as the basket average we mentioned earlier – a ratio of 27 – their market cap would fall to ...Oct 4, 2023 · Ginkgo Bioworks (DNA 8.53%) is a biotech unlike any other, and it's no surprise why it's consistently attracting the attention of bigwig portfolio managers like Cathie Wood. Wood's confidence in ...
Earnings for Ginkgo Bioworks are expected to grow in the coming year, from ($0.37) to ($0.30) per share. Ginkgo Bioworks has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 6th, 2024 based off prior year's report dates. Read More.há 5 dias ... In this video, we look at fundamentals of DNA - Ginkgo Bioworks Holdings Class A Common Stock with an AI. We will use quarter of 2023 / 6 ...The world’s most popular fruit is facing extinction. Gene editing could save it. Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet—biology—to grow better products. Our cell programming platform enables the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals.Select Year: Date Filing Type Filing Description Download. 11/28/2023. 144. Report of proposed sale of securities. 11/27/2023. 4. Statement of Changes in Beneficial Ownership. 11/27/2023.In 2022’s first quarter, Ginkgo Bioworks reported a net earnings loss that widened considerably. Shockingly, the company’s net loss deepened from $74.78 million in the first quarter of 2021 ...Ginkgo Bioworks Holdings Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 29, 2023 7:59 p.m. EST Delayed quote $ 1.4200 0.03 2.16% After Hours Volume: 270.43K Advanced... Jul 13, 2022 · Ginkgo Bioworks ( NYSE: DNA) is a leading synthetic biology company that went public through a SPAC in 2021. A large amount of hype has surrounded Ginkgo due to its ambitions, and it managed to ... Ginkgo Bioworks went public two years ago via a special purpose acquisition company. Deep losses and significant cash burn have made investors wary of investing …Ginkgo Bioworks SPAC IPO. The transaction values Ginkgo Bioworks at $15 billion. The deal is expected to provide up to $2.5 billion in cash proceeds. This includes $1.725 billion from Soaring Eagle’s trust and $775 million from a private investment in public equity (PIPE). The PIPE prices shares of Ginkgo Bioworks stock at $10.
1,292. Jason Kelly. https://www.ginkgobioworks.com. Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum.
Aug 11, 2023 · This week was one to forget for Ginkgo Bioworks ( DNA 5.80%) shareholders. In the Monday-to-Friday period, their investment lost slightly more than 8% of its value on the stock market, according ...
Jul 25, 2022 · Two major developments, including a big acquisition, are moving DNA stock today. Ginkgo Bioworks ( DNA) has agreed to acquire Bayer’s ( BAYRY) research and development center. Furthermore ... 6 de mar. de 2023 ... The Price is Finally Right. As we mentioned earlier, Ginkgo Bioworks stock is finally trading at a simple valuation ratio (market cap/annualized ...On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal. On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer.Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.For those who are bullish on Ginkgo Bioworks, today's sell-off represents a good buying opportunity. The stock's drop doesn't reflect a fundamental concern that …Ginkgo Bioworks Company Info. Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and ... Ginkgo Bioworks Holdings, Inc. (DNA) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 1.4200 +0.1300 (+10.08%) As of 03:32PM EST. Market open. 1d 5d 1mGinkgo Bioworks originally told investors to expect full-year 2022 revenue of at least $160 million from the biosecurity unit. That was increased to at least $210 million in May and increased to ...Wondering where to invest your money? Compare real estate vs. stocks and find the most profitable investment for your financial situation. Compare real estate vs. stocks and find the most profitable investment for your financial situation. ...
Ginkgo Bioworks Holdings, Inc. provides horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals.Ginkgo Bioworks Holdings Inc (DNA) share price as of December 1, 2023, is $1.43. If you are investing from India, you can always check the valuation in the INR ...The combined company is named Ginkgo Bioworks Holdings, Inc., and the combined company's shares of Class A common stock and public warrants will begin trading today on the New York Stock Exchange ...Instagram:https://instagram. 1964 liberty half dollar worthlucd stockus penny design 2009sqqq futures The End of the Beginning: Ginkgo Goes Public. Last Friday, the Ginkgo team and their families rang the opening bell at the New York Stock Exchange announcing our debut as a publicly traded company under the NYSE ticker DNA, after raising $1.6 billion to accelerate our mission to make biology easier to engineer. vanguard 2040 fundusaa progressive motorcycle insurance Find real-time DNA - Ginkgo Bioworks Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. ... Ginkgo Bioworks Holdings Inc (NYSE:DNA) Real-Time Quotes. 1.39.Complete Ginkgo Bioworks Holdings Inc. stock information by Barron's. View real-time DNA stock price and news, along with industry-best analysis. top american forex brokers Ginkgo Bioworks Reports Fourth Quarter and Full Year 2022 Financial Results. $478 million of total revenue in 2022, representing an increase of 52% over 2021 and toward the high end of guidance ...One of the most bullish investors in Ginkgo Bioworks is Cathie Wood, the CEO of Ark Invest. Just in October alone Wood has bought roughly 5 million shares in Ginkgo Bioworks across several of her ...